Robotic Exoskeletons: The Ultimate Guide

An exoskeleton is a robot you wear, and that single fact makes it the hardest control problem in the whole field. Every other robot gets to treat its environment as an obstacle to be sensed and avoided. An exoskeleton is bolted to the most sensitive, most variable, most litigious object in the room: a human body that has its own nervous system, its own plans, and no patience for a machine that fights it. The device shares joints with a person, moves in lockstep with muscle, and has to guess what the wearer intends to do a few tens of milliseconds before they do it. Get the timing and the force right and the person forgets they are wearing anything, the box they lift feels lighter, the leg that will not move takes a step. Get it wrong and you have strapped a powered actuator across a human knee that is now pushing when it should pull.

The field splits cleanly by what the device is for. Industrial and occupational exoskeletons reduce the load on a worker's back or shoulders during lifting and overhead work, and most of the ones actually deployed are passive springs, not motors. Medical and rehabilitation exoskeletons drive the legs of people with spinal cord injury or stroke through a gait pattern, either to let them walk or to retrain a nervous system. Military exoskeletons promise to let a soldier carry more, march farther, and tire less, and after two decades of prototypes they remain mostly prototypes. Underneath all three sit the same engineering questions: how do you actuate a human joint, how do you know what the person wants, how do you carry the power, and how do you make the thing comfortable enough that anyone will strap it on for eight hours.

This guide works through the categories, the actuation and control that make them go, the human-in-the-loop problem at the center of all of it, the evidence on whether they actually reduce metabolic cost and injury, the safety standards, the companies shipping product in 2026, and where the soft-exosuit line is heading.

The take: The human-machine interface decides whether an exoskeleton succeeds or fails, and peak torque is secondary. The device shares joints with a person, so it must detect intent (from EMG, IMU-derived gait phase, or foot force) and deliver assistive torque in a narrow timing window, through a transmission compliant enough (series-elastic actuators, Bowden cables, springs) that a stumble or a mistimed push does not injure the wearer. The winning products so far are the humble ones: passive back and shoulder supports that offload load with springs and clutches, and clinical rehab machines used under supervision. Powered, untethered, general-purpose augmentation is still limited by battery energy density and by the metabolic cost of carrying the actuators you added.

Companion reading: robot actuators, robot sensors, soft robotics, real-time control systems, and robot power & batteries.

Table of contents

1. Key takeaways
2. The categories: industrial, medical, military; powered vs passive
3. Actuation: electric, series-elastic, Bowden cable, passive
4. Human-in-the-loop control and intent detection
5. Power, weight, and the parasitic-mass problem
6. Fit, comfort, and the interface that decides everything
7. The evidence: metabolic cost and injury reduction
8. Safety, standards, and regulation
9. The players and their systems
10. Unit economics and adoption
11. Soft exosuits and where the field is heading
12. Frequently asked questions

The categories: industrial, medical, military; powered vs passive

Two axes organize the whole field. The first is the application domain. The second is whether the device adds energy (powered) or only redirects and stores it (passive). Almost every product on the market sits at a specific point on that grid, and the point determines the price, the battery, the regulatory burden, and whether anyone actually wears it.

Occupational and industrial exoskeletons target the injuries that dominate workers' compensation claims: lower-back strain from repetitive lifting and bending, and shoulder fatigue from sustained overhead work (assembly, welding, drywall, aircraft manufacturing). The devices are body-region specific. Back-support exos put a moment across the hips to reduce the torque the erector spinae muscles have to generate when you hinge forward. Shoulder-support exos hold the arms up against gravity for overhead tasks, offloading the deltoid and rotator cuff. The overwhelming majority sold are passive: a spring or elastic element stores energy as you bend and returns it as you rise, or a spring-loaded arm support carries the weight of your own limbs. They cost hundreds to a few thousand dollars, weigh a few kilograms, and need no charging.

Medical and rehabilitation exoskeletons are the powered, high-value end. Gait-training and mobility devices drive the hip and knee (sometimes ankle) joints of a person who cannot drive them unaided, either because of spinal cord injury, stroke, multiple sclerosis, or cerebral palsy. Two sub-goals matter: mobility (letting a wheelchair user stand and walk, as with the ReWalk personal device) and therapy (retraining the nervous system through many repetitions of a correct gait pattern in a clinic, as with EksoNR). These are regulated medical devices, cost tens of thousands to low hundreds of thousands of dollars, and mostly operate under clinical supervision or with crutches and trained users.

Military exoskeletons aim to augment an already-capable body: carry more load, march farther, reduce fatigue and musculoskeletal injury on dismounted soldiers who routinely haul 45 kg or more. The US programs (going back to Berkeley's BLEEX and the DARPA-funded work, through Lockheed's ONYX knee exo and the Sarcos full-body suits) have produced impressive demos and very few fielded systems. The blockers are the same ones that limit augmentation everywhere: battery energy for an untethered powered suit, and the metabolic penalty of the suit's own mass. Passive load-transfer frames that route a rucksack's weight to the ground through a rigid structure are the more practical military line.

Rule of thumb: If the task only needs you to hold a posture or recover energy you already put in, a passive spring device will win on cost, weight, and reliability. Reserve powered actuation for tasks that need net positive work added: driving a paralyzed leg, or assisting a genuinely heavy dynamic lift.

Actuation: electric, series-elastic, Bowden cable, passive

How you put torque across a human joint is the core mechanical decision. The options trade force fidelity, weight, back-drivability, and safety. For the general treatment of these mechanisms see robot actuators; here is what changes when the load is a person.

Passive elements. Springs, elastic bands, gas struts, and clutches. A back exo stores energy in an elastic element as the torso flexes forward and returns it during extension, so the muscles do less work over the cycle. A shoulder exo uses a spring or gas strut tuned to counter the gravitational moment of the raised arm. The clever passive designs add a clutch: Steve Collins and Gregory Sawicki's unpowered ankle exoskeleton (published in Nature, 2015) used a mechanical clutch that engaged a spring in parallel with the calf only during stance, storing energy and offloading the soleus, then disengaged for swing so the spring did not fight the free leg. It cut the metabolic cost of walking by about 7 percent with no motor and no battery at all. Passive is often the right answer.

Electric drives with a gearbox. The powered standard: a brushless DC motor through a high-ratio gearbox (planetary or harmonic) to get human-scale torque, tens to over a hundred newton-meters at the hip and knee, from a small fast motor. The problem is that a high-ratio gearbox is not back-drivable: it resists the wearer's own motion, which is exactly wrong for a device that must let a person move freely when it is not actively assisting. That resistance is why raw geared motors on limbs feel like wading through molasses.

Series-elastic actuators (SEA). The dominant solution to the back-drivability and force-control problem. Put a compliant element (a spring) deliberately in series between the gearbox output and the joint. Measuring the spring's deflection gives you a direct, high-fidelity reading of the torque being delivered (Hooke's law: force is deflection times stiffness), which turns a hard-to-control position source into a clean force source. The spring also mechanically low-passes shock loads: when the wearer stumbles or the leg hits the ground, the spring absorbs the impact instead of transmitting a rigid jolt through the gearbox into the person. SEAs trade some control bandwidth for safety and force fidelity, and that trade is almost always correct for a wearable. The concept traces to Gill Pratt and Matthew Williamson's 1995 series-elastic actuator work at MIT and is now standard across powered rehab exos.

Bowden-cable (remote) transmission. The trick that makes soft exosuits possible. Instead of mounting the heavy motor and gearbox at the joint, you mount them on the torso or in a waist pack and transmit force to the limb through a Bowden cable (a tension cable in a sheath, exactly like a bicycle brake). This moves parasitic mass off the fast-moving distal limb, where added weight costs the most metabolic energy, and onto the trunk near the body's center of mass, where it costs the least. Conor Walsh's Harvard Biodesign Lab built its ankle and hip exosuits around cable drives for precisely this reason. The cost is friction and compliance in the cable itself, which the control loop has to model and compensate.

Hydraulic and pneumatic. High force density, which is why Sarcos used hydraulics for the full-body Guardian XO meant to lift 90 kg. But hydraulics bring pumps, fluid, weight, and complexity that fit a tethered or heavily-powered industrial suit far better than a lightweight wearable. Pneumatic artificial muscles (McKibben actuators) are inherently compliant and lightweight, attractive for soft devices, but hard to control precisely and needing a compressed-air source.

Rule of thumb: Compliance is a feature when the load is a human. A series spring or a cable that gives a little is what keeps a mistimed actuator command from becoming an injury. Rigid, non-back-drivable drives belong on machines that do not share joints with people.

Human-in-the-loop control and intent detection

This is where exoskeletons diverge from every other robot. The control loop closes around a human being. The device must sense what the wearer intends, deliver assistance at the right instant, and never fight the person. The whole discipline of human-in-the-loop control lives here, and it leans on the same hard-real-time execution discussed in real-time control systems.

Intent detection is the sensing half. Several signals are used, often fused:

• Surface EMG (electromyography). Electrodes on the skin pick up the electrical activity of muscle contraction, which precedes and predicts the mechanical force. This is the signal before the movement, so it gives the earliest possible intent estimate. Cyberdyne's HAL is built entirely around this idea: it reads the bioelectric signals the wearer's own nervous system sends to the muscle and drives the joint in proportion, so the person's intention commands the machine. EMG is powerful and also fussy: it drifts with sweat, electrode placement, fatigue, and skin condition, and it needs per-user calibration.
• IMU-based gait phase. Inertial measurement units on the limbs and torso (accelerometers and gyroscopes, the same parts covered in robot sensors) track segment angles and angular velocities, and an estimator infers where in the gait cycle the wearer is (heel strike, stance, toe-off, swing). Assistance is then scheduled against gait phase by a finite-state machine. Robust, cheap, no skin contact, and the workhorse of most walking-assistance devices.
• Foot force and pressure. Load cells or insole pressure sensors detect ground contact and weight transfer, the cleanest signal for segmenting stance from swing and for deciding which leg to assist.
• Joint encoders and interaction-force sensors. Encoders read joint angle; force or torque sensors at the cuffs read how hard the person is pushing against the device, which admittance and impedance controllers use to move with the wearer rather than against them.

The control strategies built on those signals:

• Finite-state / gait-phase control is the mainstay of rehab and walking exos: detect the phase, apply the pre-planned assistive torque profile for that phase, transition on sensed events. Simple, robust, predictable.
• Impedance and admittance control make the joint behave like a tunable spring-damper, so the device yields to the wearer with a programmed stiffness. Lower stiffness when the person should lead, higher when the device should guide. This is how a rehab device can go from "assist as needed" to fully driving a flaccid limb.
• Proportional myoelectric control maps EMG amplitude directly to output torque, the HAL approach: the harder the intact muscle signal, the more the machine helps. It keeps the human firmly in the loop and is well suited to therapy where you want the wearer's own effort to drive the assistance.
• Human-in-the-loop optimization (HILO). The frontier. Rather than hand-tuning a torque profile, the controller searches the space of assistance parameters while the person walks, measuring their physiological response (metabolic rate from respiratory gas analysis, or a faster proxy) and adapting to minimize effort for that individual. Steven Collins's group at Stanford used HILO to push optimized ankle exoskeletons to large metabolic reductions, and their 2022 Nature paper demonstrated a portable ankle exoboot that learned an individual's optimal assistance on a treadmill and cut the metabolic cost of walking by roughly 17 percent. The insight is that the best assistance is deeply personal, and no fixed profile fits everyone.

War story: Early powered lower-limb exos that scheduled a fixed torque profile against a fixed gait timing worked beautifully on the one subject and one speed they were tuned on, then fought the next user whose cadence differed by 10 percent. The device would push for toe-off while the wearer was still in stance. The fix was to close the loop on the actual person: estimate this wearer's gait phase in real time and, better still, optimize the assistance to this wearer's physiology. Intent detection is the product.

Power, weight, and the parasitic-mass problem

A powered exoskeleton has to carry its own energy, and this is the constraint that quietly kills most ambitious designs. See robot power & batteries for the underlying chemistry; the wearable-specific issue is a vicious feedback loop between mass and energy.

Every gram you add to the device must be carried by the wearer, and mass added far from the body's center of mass, out near the foot or the hand, costs the most metabolic energy to swing. Biomechanics studies going back decades quantify it: a kilogram added at the foot raises the metabolic cost of walking several times more than the same kilogram at the waist. So the actuators, gearboxes, and batteries you add to help the wearer also tax them, and if the tax exceeds the assistance, the device makes walking harder while claiming to make it easier. This is the parasitic-mass problem, and it is why so many powered exos show a net metabolic penalty in honest testing.

The design responses all attack the same loop. Move the heavy parts to the torso via Bowden cables. Use passive springs to supply the assistive energy so you need less battery, or no battery. Minimize the number of powered joints (assist only the ankle, or only the hip, rather than a full lower-body suit). And accept a tether where you can: clinical rehab devices and industrial suits at a fixed station can run off wall power or a large fixed battery precisely because untethered energy is so expensive.

For the untethered devices that do carry batteries, lithium-ion packs give a few hours of assisted operation for an occupational back exo drawing modest average power, and less for a full gait-drive rehab device working hard against gravity. German Bionic's powered back-support suits, for instance, are built around swappable battery packs sized for a work shift, with the electronics kept light and the assistance intermittent (spiking during a lift, idling between). The rehab exos that walk a full body around draw far more and are correspondingly heavier and shorter-lived per charge.

Rule of thumb: The metabolic budget is unforgiving. Before adding a powered joint, ask whether the assistance it delivers exceeds the metabolic cost of the mass it adds, especially if that mass sits below the knee. Often the answer is no, and a spring is better.

Fit, comfort, and the interface that decides everything

An exoskeleton that works in a lab and sits in a closet at the job site has failed, and the reason is almost always the physical interface. The device attaches to the body through cuffs, straps, and pads, and every one of those contact points is a place where a rigid machine meets soft, mobile tissue.

The mechanical problems are specific. Human joints are not simple hinges: the knee's instantaneous center of rotation migrates as it flexes, and the hip is a ball joint with three rotational degrees of freedom. A rigid exoskeleton with a single pin joint will misalign with the biological joint through the range of motion, and that misalignment shows up as the cuffs sliding on the skin, pressure points, shear, and eventually pain and pressure sores. Serious designs add passive degrees of freedom (self-aligning joints, sliding attachments) so the frame can accommodate the joint's real kinematics rather than fighting them.

Comfort is the adoption gate. A worker will not wear a device that chafes, overheats, restricts natural movement, or is annoying to don and doff. Donning time matters: a suit that takes ten minutes and a helper to put on will not survive contact with a real shift. Weight distribution matters: pressure spread over a large padded area is tolerable, the same force through a narrow strap is not. Thermal load matters: rigid structures and straps trap heat, and a hot device is an unworn device. Soft exosuits, made of textile and webbing, address much of this by conforming to the body and moving with it, which is a large part of why the field is drifting toward fabric.

Safety rule: Joint misalignment is a safety issue as much as a comfort one. A powered device whose axis does not track the biological joint applies unintended forces through the range of motion. Self-aligning mechanisms and generous compliant padding are load-bearing safety features.

The evidence: metabolic cost and injury reduction

The honest state of the evidence in 2026 is: measurable, modest, and better characterized for laboratory metabolics than for real-world injury outcomes.

Metabolic cost of walking. This is the most rigorously studied benefit because it can be measured directly through respiratory gas analysis (oxygen consumption is the gold-standard proxy for metabolic effort). The results:

Device type	Reported effect on walking metabolic cost	Source line of work
Unpowered clutch-spring ankle exo	~7% reduction	Collins & Sawicki, Nature 2015
Tethered powered ankle exo, hand-tuned	~10 to 15% reduction	Multiple lab studies, 2013 onward
Ankle exo with human-in-the-loop optimization	~15 to 25% reduction	Zhang, Collins et al, Science 2017
Portable autonomous ankle exoboot, HILO-trained	~17% reduction (walking)	Slade, Kim, Collins et al, Nature 2022
Hip-assist exosuit (Harvard)	~10 to 17% reduction (walk/run)	Walsh Biodesign Lab

The pattern is clear: the benefit is real, it grows with per-user optimization, and it is on the order of 10 to 25 percent for the best lab devices assisting a single joint. That is meaningful (comparable to shedding a substantial backpack), but it is not the order-of-magnitude augmentation that popular coverage implies, and it evaporates if the device's own mass is not tightly controlled.

Injury reduction and occupational load. Here the primary evidence is surrogate measures: back exos measurably reduce the electrical activity (EMG) of the erector spinae muscles during lifting, often by 10 to 40 percent, and reduce peak compressive load on the lumbar spine in biomechanical models, and reduce self-reported fatigue and perceived exertion. Shoulder exos similarly cut deltoid activity during overhead work. Those are real, repeatable findings. What is thinner is long-term, controlled data linking the devices to lower actual injury rates in the field over months and years, because such studies are expensive, slow, and confounded. NIOSH and academic reviews have been appropriately cautious: they note the surrogate benefits while flagging that devices can shift load elsewhere (a back exo may increase demand on the legs or abdomen), can interfere with balance or other tasks, and lack the long-horizon outcome data that would settle the question. The rehab side has stronger clinical evidence for specific outcomes (standing, stepping, and functional gains for spinal-cord-injury and stroke patients under supervised programs), which is why those devices carry regulatory clearances tied to clinical claims.

Rule of thumb: Treat vendor metabolic and injury claims as best-case, single-joint, lab-optimized numbers. In the field, expect a fraction of the headline benefit, and demand surrogate data (EMG, load) at minimum and controlled outcome data where a vendor claims injury reduction.

Safety, standards, and regulation

A robot strapped to a person is a safety-critical device, and the standards landscape has matured to match.

• ISO 13482:2014 ("Robots and robotic devices, safety requirements for personal care robots") is the foundational safety standard covering physical-assistant robots, which explicitly includes exoskeletons that assist or restrain body motion. It addresses hazards specific to wearing a robot: unintended motion, excessive force, instability, and the human-robot contact itself.
• ASTM F48 is the dedicated committee on Exoskeletons and Exosuits, writing the field-specific standards: terminology, testing methods for load handling and range of motion, ergonomic and labeling requirements, and task-performance measures. This is the body actively filling the exoskeleton-specific gaps.
• IEC 80601-2-78 covers the safety and essential performance of medical rehabilitation robots that assess or assist movement, the standard that clinical exos are built against.
• Medical device regulation. In the US, powered lower-extremity exoskeletons for medical use are FDA-cleared as Class II devices (ReWalk received the first such clearance for a personal SCI exoskeleton in 2014, followed by Ekso, Indego, and others). Clearance is tied to specific indications, user populations, and required training. In the EU they fall under the Medical Device Regulation.
• Occupational devices generally are not medical devices and instead sit under workplace safety, machinery, and PPE frameworks, which is part of why the occupational market moves faster: less regulatory friction than the medical path.

The core safety hazards a designer must engineer against: applying force in the wrong direction or at the wrong time (mitigated by compliant actuation and conservative control that yields to the wearer), joint misalignment forces (mitigated by self-aligning mechanisms), falls (a powered lower-limb device must fail safe and not lock a leg or throw the wearer off balance), pressure injury from cuffs, and the classic failure modes of any battery-powered wearable. The general discipline is the same functional-safety thinking applied across robotics, here with the extra weight that the object at risk is the operator's own body.

Safety rule: A wearable robot must fail safe toward the human. On loss of power, a sensor fault, or an out-of-bounds command, the correct behavior is to become a passive, back-drivable, non-actuated structure the wearer can move freely, never to lock a joint or drive it. Design the failure mode first.

The players and their systems

The commercial field is small, specialized, and split by domain. Named, factual, as of 2026:

Medical and rehabilitation:

• Ekso Bionics (US, public). The clinical rehabilitation leader with EksoNR, a lower-body powered exoskeleton used in hospitals and rehab clinics to retrain gait after stroke, spinal cord injury, and brain injury, walking under therapist supervision. Ekso also makes EksoUE / EVO, a passive upper-body and shoulder-support exo for industrial overhead work, one of the more widely deployed occupational devices.
• ReWalk Robotics / Lifeward (Israel/US, public; rebranded Lifeward). Pioneer of the personal SCI exoskeleton: the ReWalk Personal device (first FDA clearance for personal use, 2014) lets paraplegic users stand and walk with crutches, detecting intent from upper-body tilt. Lifeward also fields the ReStore soft exo-suit for stroke gait therapy and has broadened into other rehab technology.
• Wandercraft (France). Builder of Atalante, a self-balancing, hands-free lower-body exoskeleton (no crutches needed, the device balances itself), used in rehab clinics and moving toward a personal version. Wandercraft's dynamic self-balancing is a genuinely distinct technical bet in the field.
• Cyberdyne (Japan, public). Maker of HAL (Hybrid Assistive Limb), the EMG-driven exoskeleton that reads the wearer's bioelectric signals to command assistance. HAL comes in medical lower-limb versions (used in Japan and Europe for neuromuscular therapy, with reimbursement in some systems) and a HAL Lumbar back-support version for care work and labor.
• Parker Hannifin's Indego, a modular lightweight SCI exoskeleton, is another FDA-cleared clinical and personal device in this segment.

Occupational and industrial:

• German Bionic (Germany). Powered back-support exosuits (the Cray X and successor Apogee lines) with cloud connectivity and analytics, aimed at logistics and manufacturing lifting. Among the more prominent powered occupational players.
• Ottobock (Germany). The prosthetics and orthotics giant, in exos through its Paexo line: passive shoulder, back, and wrist supports for industrial work, lightweight and battery-free. Ottobock acquired SuitX (the Berkeley-spinout occupational exo maker) in 2021, consolidating the passive-occupational segment.
• Hilti (with Ottobock) fields the EXO-O1, a passive overhead-work shoulder exo for construction. Comau (MATE) offers a passive spring-based shoulder exo. Levitate Technologies (Airframe) and HeroWear (Apex, a passive back exosuit) round out the passive occupational field. Hyundai has demonstrated the passive VEX (vest exoskeleton) and CEX (chairless) devices for its plants.
• Roam Robotics and Dephy work the lighter powered/assistive end (knee and ankle assist), with Dephy's ExoBoot line coming out of the human-in-the-loop-optimization research lineage.

Military and heavy augmentation:

• Sarcos (US) built the Guardian XO, a full-body powered exoskeleton meant to let a worker lift up to ~90 kg, one of the most ambitious powered suits ever demonstrated. Sarcos paused Guardian XO commercialization around 2022 to 2023 (the untethered-power and cost economics did not close) and pivoted to AI software as Palladyne AI, a telling data point about where powered full-body augmentation stands.
• Military programs (Lockheed Martin's ONYX knee exo, and the earlier DARPA/Berkeley lineage) have produced fielded-adjacent prototypes but no widespread deployment, with untethered power remaining the central blocker.

You can browse current robot and wearable platforms and their specs on the robo2u leaderboards at data.robo2u.com.

Unit economics and adoption

The economics differ so sharply by domain that they barely belong in the same paragraph.

Occupational. A passive shoulder or back exo runs roughly a few hundred to a few thousand dollars per unit. The buyer is an employer, and the return is measured against workers' compensation claims, lost-time injuries, and productivity. Back and shoulder musculoskeletal injuries are among the most costly and common workplace claims, so even a modest reduction in injury frequency or severity can justify a device that costs less than a single lost-time claim. That math, plus the light regulatory burden and zero maintenance of a passive device, is why the occupational passive segment is the one showing real volume growth. Powered occupational suits (German Bionic and similar) cost more, into the low tens of thousands, and have to justify the added cost and the battery-charging logistics with proportionally more assistance on genuinely heavy tasks.

Medical. A clinical rehab exoskeleton (EksoNR, Atalante) costs on the order of $100,000 to $150,000, sold to hospitals and rehab centers where it is used across many patients, so the per-session economics can work through billing and throughput. A personal mobility exoskeleton for an individual with spinal cord injury has historically cost roughly $70,000 to $100,000, and the adoption blocker there is reimbursement: whether insurers or health systems will pay. Coverage has expanded slowly (the US VA has provided personal exoskeletons to eligible veterans, and some private and national systems reimburse specific devices), and reimbursement decisions, more than technology, gate the personal-mobility market.

Military. No meaningful unit economics yet, because there is no meaningful fielded volume. The programs remain in development and evaluation.

The through-line: adoption tracks the value equation and the friction, not the impressiveness of the demo. Cheap passive devices with a clear injury-cost payback are spreading. Expensive powered devices spread only where a payer (a hospital's throughput, an insurer, a veterans' system) covers the cost, or where the task genuinely needs the power.

Soft exosuits and where the field is heading

The clearest trajectory in the field is from rigid frames toward soft, textile-based exosuits, and it follows directly from everything above: the interface decides adoption, compliance is a safety feature, and distal mass is metabolically expensive. Soft exosuits, pioneered largely by Conor Walsh's Harvard Biodesign Lab and drawing on the broader soft robotics toolkit, replace the rigid exoskeleton frame with functional apparel: webbing, textile anchors, and Bowden cables that apply force across the body's own skeleton rather than through a parallel metal structure.

The advantages line up with the pain points. A textile suit conforms to the body, so joint-misalignment forces largely disappear (there is no rigid pin joint to misalign). It is lighter and cooler. It moves with the wearer and restricts natural motion far less. And by routing actuation through cables from torso-mounted motors, it keeps parasitic mass off the limbs. The cost is that a soft suit can only apply tension through the body's own structure, so it cannot resist or hold a posture the way a rigid frame can, and it demands more of the control system to place assistance precisely. For assisting motion (walking, running, load carriage, sit-to-stand) rather than bearing external load, the soft approach is winning the argument.

Two other threads run alongside. First, human-in-the-loop optimization is becoming portable: the same personalization that produced large lab metabolic reductions is moving onto autonomous, battery-powered devices that learn a wearer's optimal assistance in the field, beyond the tethered treadmill. Second, the control intelligence is deepening: machine learning on IMU and force data to estimate gait intent more robustly across speeds, terrains, and activities, so a device can assist walking, stair climbing, and running without hand-tuned mode switches. The field's honest near-term future is specialized and modest: better passive occupational devices with real injury-cost payback, clinically-validated rehab machines with expanding reimbursement, and light soft suits that shave a real but bounded fraction off the metabolic cost of moving. The full-body powered augmentation suit that lets anyone lift anything remains, for now, blocked by the same battery and parasitic-mass physics it has always been blocked by.

Frequently asked questions

Are most exoskeletons powered or passive? The ones with real field adoption are mostly passive. Passive occupational back and shoulder supports (springs, gas struts, clutches) dominate by volume because they are cheap, need no battery, require no maintenance, and carry a light regulatory burden. Powered devices are reserved for tasks that need net positive energy, chiefly medical gait rehabilitation and heavy dynamic lifting.

How does an exoskeleton know what I want to do? Through intent detection. Options include surface EMG (electrodes reading the muscle's own electrical command, as in Cyberdyne HAL), IMU-based gait-phase estimation (inertial sensors inferring where you are in the walking cycle), foot-force and pressure sensors detecting ground contact, and joint encoders plus interaction-force sensors. Most devices fuse several and schedule assistance against the estimated state.

What is a series-elastic actuator and why do exoskeletons use them? A series-elastic actuator puts a spring deliberately between the motor/gearbox and the joint. Measuring the spring's deflection gives a clean, direct reading of the delivered torque, turning a hard-to-control geared motor into a precise force source. The spring also absorbs impacts and lets the device yield to the wearer, which is essential safety when a machine shares a joint with a person.

Do exoskeletons actually reduce the effort of walking? Yes, modestly. The best lab devices assisting a single joint (usually the ankle or hip) reduce the metabolic cost of walking by roughly 10 to 25 percent, with the larger figures coming from human-in-the-loop optimization that tunes assistance to the individual. Unpowered clutch-spring ankle devices reach about 7 percent with no battery at all. The benefit shrinks fast if the device's own mass is not tightly controlled.

Can an exoskeleton prevent back injury at work? The surrogate evidence is encouraging: back exos measurably cut erector-spinae muscle activity (often 10 to 40 percent) and peak spinal load during lifting, and reduce fatigue. Long-term controlled data directly linking the devices to lower injury rates is still limited, and devices can shift load to other body parts. Treat injury-prevention claims as promising but not yet fully proven.

Why did Sarcos pause the Guardian XO full-body suit? The economics of an untethered, full-body powered exoskeleton did not close. Carrying enough battery energy to power a suit that lifts 90 kg, at an acceptable weight and cost, remains the central unsolved problem. Sarcos paused commercialization around 2022 to 2023 and pivoted to AI software as Palladyne, which is a fair indicator of where general-purpose powered augmentation stands.

What standards and approvals apply to exoskeletons? ISO 13482 is the foundational safety standard for personal-care and physical-assistant robots, ASTM F48 is the dedicated exoskeleton-and-exosuit standards committee, and IEC 80601-2-78 covers medical rehabilitation robots. Medical lower-limb exoskeletons in the US are FDA-cleared Class II devices tied to specific indications and required training; occupational devices generally sit under workplace-safety and PPE frameworks instead.

Are soft exosuits better than rigid exoskeletons? For assisting motion (walking, running, load carriage), soft textile suits have real advantages: they conform to the body so joint misalignment largely disappears, they are lighter and cooler, and cable drives keep heavy motors off the limbs. The tradeoff is that a soft suit can only pull through the body's own skeleton, so it cannot bear external load or hold a posture the way a rigid frame can. The field is drifting toward soft designs for assistance and keeping rigid frames for load-bearing.

How long does a powered exoskeleton run on a charge? It depends heavily on the duty cycle. An occupational back-support suit that assists intermittently (spiking during lifts, idling between) can run a work shift on a swappable lithium-ion pack. A full lower-body rehab device driving both legs against gravity draws far more and is correspondingly heavier and shorter-lived, which is part of why clinical devices are used in supervised sessions rather than all day.

Who are the main companies to know? Medical and rehab: Ekso Bionics (EksoNR), ReWalk/Lifeward, Wandercraft (Atalante), Cyberdyne (HAL), Parker Indego. Occupational: German Bionic, Ottobock (Paexo, and it acquired SuitX), Hilti, Comau, Levitate, HeroWear, Hyundai. Heavy augmentation: Sarcos (Guardian XO, now Palladyne AI) and military programs such as Lockheed's ONYX.